BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 19654482)

  • 41. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.
    Khorana AA; Streiff MB; Farge D; Mandala M; Debourdeau P; Cajfinger F; Marty M; Falanga A; Lyman GH
    J Clin Oncol; 2009 Oct; 27(29):4919-26. PubMed ID: 19720907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE.
    Anderson FA; Goldhaber SZ; Tapson VF; Bergmann JF; Kakkar AK; Deslandes B; Huang W; Cohen AT;
    Am J Med; 2010 Dec; 123(12):1099-1106.e8. PubMed ID: 21183004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Venous thromboembolism prophylaxis in internal medicine].
    Malý J; Widimský J; Dulícek P
    Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative.
    Raffini L; Trimarchi T; Beliveau J; Davis D
    Pediatrics; 2011 May; 127(5):e1326-32. PubMed ID: 21464186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of venous thromboembolism in cancer patients.
    Lee AY
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.
    Eikelboom JW; Quinlan DJ; O'Donnell M
    Circulation; 2009 Nov; 120(20):2006-11. PubMed ID: 19884469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"].
    Dávid M; Losonczy H; Udvardy M; Boda Z; Blaskó G; Tar A; Pfliegler G
    Orv Hetil; 2010 Aug; 151(34):1365-74. PubMed ID: 20705551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
    Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
    Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Venous thrombembolism in tumour patients].
    Pabinger I; Alt-Epping B; Demarmels Biasutti F; Langer F; Wörmann B; Riess H
    Hamostaseologie; 2011 Nov; 31(4):281-90; quiz 291-2. PubMed ID: 21983992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Venous thromboembolism and prophylaxis in cancer patients.
    Paskauskas S; Pundzius J; Barauskas G
    Medicina (Kaunas); 2008; 44(3):175-81. PubMed ID: 18413983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of thromboprophylaxis in palliative care patients: a survey among experts in palliative care, oncology, intensive care, and anticoagulation.
    Kierner KA; Gartner V; Schwarz M; Watzke HH
    Am J Hosp Palliat Care; 2008; 25(2):127-31. PubMed ID: 18198364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cancer and venous thromboembolism].
    Rasmussen MS; Münster AM
    Ugeskr Laeger; 2010 Mar; 172(12):958. PubMed ID: 20334792
    [No Abstract]   [Full Text] [Related]  

  • 53. VTE in patients with cancer--diagnosis, prevention, and treatment.
    Lee A
    Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of thrombosis in ambulatory patients with cancer.
    Rana P; Levine MN
    J Clin Oncol; 2009 Oct; 27(29):4885-8. PubMed ID: 19752331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
    Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
    J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).
    Mandalà M; Falanga A; Piccioli A; Prandoni P; Pogliani EM; Labianca R; Barni S;
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):194-204. PubMed ID: 16837209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Venous thromboembolism prevention in patients with heart failure: an often neglected issue.
    Imberti D; Pierfranceschi MG; Falciani M; Prisco D
    Pathophysiol Haemost Thromb; 2008; 36(2):69-74. PubMed ID: 19127085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of venous thromboembolism in hospitalized medical patients.
    Lenchus JD; Jaffer AK
    Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improvement of venous thromboembolism prophylaxis by attaching printed thrombosis risk assessment tool and recommendations to patients hospital charts.
    Rahimni-Rad MH; SeidSalehi S
    Pneumologia; 2010; 59(3):140-3. PubMed ID: 21053646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.